Srinivas V Kaveri Selected Research

Hemorrhagic Disorders (Hemorrhagic Diathesis)

1/2019	Prevention of the anti-factor VIII memory B-cell response by inhibition of Bruton tyrosine kinase in experimental hemophilia A.
6/2008	Factor VIII hydrolysis mediated by anti-factor VIII autoantibodies in acquired hemophilia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Srinivas V Kaveri Research Topics

Disease

27	Hemophilia A (Haemophilia) 01/2020 - 11/2002
6	Infections 04/2021 - 04/2005
6	Inflammation (Inflammations) 07/2014 - 04/2005
5	Hemorrhage 01/2020 - 07/2008
4	Neoplasms (Cancer) 04/2021 - 09/2007
4	Sepsis (Septicemia) 07/2010 - 04/2005
3	Communicable Diseases (Infectious Diseases) 04/2021 - 12/2011
3	Thrombosis (Thrombus) 01/2014 - 04/2005
2	Hemorrhagic Disorders (Hemorrhagic Diathesis) 01/2019 - 06/2008
2	Hemolysis 02/2015 - 05/2011
2	Virus Diseases (Viral Diseases) 12/2010 - 07/2009
1	COVID-19 04/2021
1	Diphtheria 04/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2020
1	Tuberculosis (Tuberculoses) 01/2016
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 07/2014
1	Lymphoma (Lymphomas) 07/2014
1	Obesity 06/2014
1	Type 2 Diabetes Mellitus (MODY) 06/2014
1	Coinfection 01/2013
1	Septic Shock (Toxic Shock Syndrome) 07/2010
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 04/2010
1	Autoimmune Diseases (Autoimmune Disease) 10/2009
1	HIV Infections (HIV Infection) 05/2008
1	Pathologic Processes 09/2007
1	Ischemia 06/2006
1	Asthma (Bronchial Asthma) 11/2002
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2002
1	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 11/2002

Drug/Important Bio-Agent (IBA)

25	Factor VIII (Coagulation Factor VIII)IBA 01/2020 - 11/2002
17	AntibodiesIBA 04/2021 - 11/2002
13	Immunoglobulin G (IgG)IBA 01/2020 - 11/2002
8	AntigensIBA 01/2020 - 01/2006
5	Immunoglobulins (Immunoglobulin)IBA 02/2015 - 01/2006
4	Heme (Haem)IBA 02/2015 - 09/2007
3	VaccinesIBA 04/2021 - 07/2009
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2007
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2013 - 04/2010
3	AutoantibodiesIBA 01/2012 - 06/2008
2	von Willebrand FactorIBA 01/2019 - 10/2007
2	Neutralizing AntibodiesIBA 01/2018 - 12/2009
2	CytokinesIBA 06/2014 - 10/2009
2	IsoantibodiesIBA 08/2009 - 06/2008
2	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2008 - 01/2006
2	Catalytic AntibodiesIBA 04/2005 - 11/2002
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2020
1	prothrombin complex concentrates (PPSB)IBA 01/2020
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2020
1	Anti-Idiotypic AntibodiesIBA 01/2020
1	AntithrombinsIBA 01/2020
1	Factor X (Stuart Factor)IBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	Mannose (D-Mannose)IBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Polysaccharides (Glycans)IBA 01/2020
1	Protein CIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	SerpinsIBA 01/2020
1	Factor VIIa (Activated Factor VII)IBA 01/2020
1	Factor IXa (Coagulation Factor IXa)IBA 01/2020
1	Fluorescein-5-isothiocyanate (FITC)IBA 01/2020
1	CoagulantsIBA 01/2019
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2019
1	AnaphylatoxinsIBA 01/2018
1	cobra venom factorIBA 01/2018
1	Cysteine (L-Cysteine)FDA Link 01/2018
1	Complement C3 (C3 Complement)IBA 01/2018
1	Dinoprostone (PGE2)FDA Link 04/2016
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 04/2016
1	Immunodominant EpitopesIBA 02/2015
1	AutoantigensIBA 07/2014
1	Glucose (Dextrose)FDA LinkGeneric 06/2014
1	Interleukin-22 (IL-22)IBA 06/2014
1	Complement System Proteins (Complement)IBA 01/2014
1	EnzymesIBA 10/2013
1	Heme Oxygenase-1IBA 10/2013
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 02/2011
1	BuffersIBA 07/2010
1	LipopolysaccharidesIBA 07/2010
1	Pharmaceutical PreparationsIBA 07/2008
1	Glycoproteins (Glycoprotein)IBA 07/2008
1	Hemostatics (Antihemorrhagics)IBA 07/2008
1	Biological ProductsIBA 07/2008
1	Mannose ReceptorIBA 09/2007
1	Transferrin (beta 2 Transferrin)IBA 01/2006
1	Ferritins (Ferritin)IBA 01/2006
1	IonsIBA 01/2006
1	Serine Proteases (Serine Protease)IBA 04/2005
1	Peptide Hydrolases (Proteases)FDA Link 11/2002

Therapy/Procedure

12	Therapeutics 04/2021 - 11/2002
2	Immunotherapy 06/2014 - 07/2009